Budget 2018-19

  DRL to manufacture oral drug, which reduces oxygen dependency in patients Defence Minister Rajnath Singh on Monday released the first batch of a keenly awaited anti-Covid-19 drug called 2-deoxy-D-glucose (2-DG). It has been developed by the Defence Research and Development Organisation (DRDO), in partnership with Hyderabad-based private firm Dr Reddy’s Laboratories (DRL). The new drug is not a vaccination, or a preventive measure against being infected by coronavirus. Rather, the 2-DG molecule hastens the recovery of patients who are already suffering from the disease and are, in most cases, facing severe oxygen dependency. The drug is dispensed in powder form in a sachet, and taken orally after being dissolved in water. Rajnath Singh handed over the first batch of the drug in Delhi to the Minister for Health & Family Welfare, Science & Technology and Earth Sciences, Harsh Vardhan. DRL Chairman Kallam Satish Reddy said his company would “increase the production ...

  Rajnath Singh said that despite challenging times due to Covid-19 and disputes caused by Pakistan and China, India was not only resolutely facing them but also bringing about historical changes Defence Minister Rajnath Singh said on Monday that despite challenging times due to Covid-19 and border tensions and disputes caused by Pakistan and China, India was not only resolutely facing them but also bringing about historical changes in all sectors of development under Prime Minister Narendra Modi’s able leadership. Reiterating the Centres’ commitment to boost developmental activities in India’s border areas, the Minister said that progress in all such projects is regularly monitored and adequate funds provided for timely execution. The Minister on Monday dedicated to the nation via videoconference 44 major permanent bridges built in seven border states and Union Territories in western, northern and north-eastern India and also laid the foundation of important Nechiphu tunnel in Aru...